What are the recommended colorectal cancer screening guidelines for average‑risk adults (age 45‑75) and for higher‑risk individuals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colorectal Cancer Screening Recommendations

Average-Risk Adults: Start Screening at Age 45-50

Begin colorectal cancer screening at age 45 for average-risk adults, though age 50 remains the most evidence-based starting point with strong recommendation strength, while age 45 screening is a qualified recommendation based on weaker evidence. 1, 2, 3

Starting Age Algorithm:

  • Age 50 and older: Strong recommendation to screen all average-risk adults 1, 4
  • Age 45-49: Qualified recommendation based on rising CRC incidence in younger adults, but weaker evidence quality 1, 2, 4
  • The shift to age 45 reflects modeling analyses showing efficient screening at this younger age, driven by increasing CRC rates in adults under 50 2

First-Tier Screening Options

Offer colonoscopy every 10 years or annual FIT as the cornerstones of screening and first-line options. 2, 3, 5

Colonoscopy Every 10 Years:

  • Provides highest sensitivity for detecting precancerous lesions of all sizes with simultaneous removal capability 2
  • Preferred screening strategy with strongest evidence 5, 6

Annual Fecal Immunochemical Test (FIT):

  • Demonstrates 75-100% sensitivity for cancer detection, significantly superior to guaiac-based tests (30.8-64.3% sensitivity) 2
  • Appropriate for patients who decline colonoscopy 5

Second-Tier Screening Options

Offer these alternatives only when patients decline first-tier tests: 2, 4

  • Multitarget stool DNA test (Cologuard) every 3 years 2, 3
  • CT colonography every 5 years (disadvantages include radiation exposure) 2, 4
  • Flexible sigmoidoscopy every 5-10 years (examines only distal colon, missing proximal lesions) 2, 4

When to Stop Screening

Stop screening at age 75 in patients who are up-to-date with prior negative screening, particularly high-quality colonoscopy, or when life expectancy is less than 10 years. 1, 2, 3

Age-Based Stopping Algorithm:

  • Age 75 or less: Continue screening if life expectancy >10 years and not up-to-date with prior screening 1, 3
  • Age 76-85: Only offer screening to those never previously screened, considering overall health status, comorbidities, and whether healthy enough to undergo treatment if cancer detected 2, 3, 4
  • Age 86 and older: Discontinue all screening regardless of prior screening history, as harms outweigh benefits 1, 2, 4

Higher-Risk Individuals: Family History

Begin screening at age 40 or 10 years before the age of diagnosis of the youngest affected first-degree relative, whichever comes first, for individuals with family history of CRC. 4, 5, 7

Family History Risk Stratification:

  • First-degree relative with CRC or advanced adenoma diagnosed <60 years, OR 2+ first-degree relatives at any age: Colonoscopy every 5 years starting at age 40 or 10 years before youngest affected relative's diagnosis age 4, 5
  • Single first-degree relative diagnosed ≥60 years: Average-risk screening options beginning at age 40 5
  • Lynch Syndrome: Colonoscopy beginning 10 years before age at diagnosis of youngest affected relative 4

Critical Implementation Requirements

All positive results on non-colonoscopy screening tests mandate timely diagnostic colonoscopy as part of the screening process. 2, 3, 4

Common Pitfalls to Avoid:

  • Never use screening tests in symptomatic patients with alarm symptoms (rectal bleeding, narrowed stools, unexplained weight loss)—these require immediate diagnostic colonoscopy regardless of any stool test results 2, 3
  • Do not continue screening past age 75 in patients with adequate prior negative screening, as harms increasingly outweigh benefits 2, 3
  • Ensure colonoscopy capacity exists before ordering stool-based or imaging tests, as positive results require follow-up 2, 3
  • Avoid screening if life expectancy <10 years due to comorbidities, as screening unlikely to provide benefit 2, 3

Patient Selection Criteria

Use screening tests only in asymptomatic average-risk individuals—defined as those without family history of CRC, long-standing inflammatory bowel disease, genetic syndromes, or personal history of CRC or adenomatous polyps. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colonoscopy Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Colorectal Cancer Screening Age Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Colorectal cancer screening guidelines for average-risk and high-risk individuals: A systematic review.

Romanian journal of internal medicine = Revue roumaine de medecine interne, 2024

Related Questions

At what age should an average-risk individual with no significant family or medical history start colonoscopy screening for colorectal cancer?
Why is colorectal cancer screening recommended to start at 45, rather than 40, and be repeated every 10 years?
What are the recommended new imaging techniques for colorectal cancer screening?
What are the guidelines for a patient's preventive care colonoscopy?
What is the most appropriate colon cancer screening test for a 40-60 year old female with no family history of colon cancer and no prior medical or surgical issues?
A 42‑year‑old man with an acute right frontal infarct and right M1 (middle cerebral artery segment 1) stenosis received intravenous thrombolysis; two hours later he has worsening neurology with right gaze deviation, dense left hemiplegia, and repeat CT shows infarct expansion without hemorrhage. What is the next management step when no interventional radiologist is available?
For a euthymic bipolar patient on lithium 1000 mg daily and lamotrigine 200 mg daily (with quetiapine causing daytime sleepiness), should the combination be continued for 1–2 years before tapering, and what is the recommended taper schedule?
Why is the oncologist ordering a serum lactate dehydrogenase (LDH) test to assess for recurrence of non‑Hodgkin lymphoma in a patient with a known history of the disease?
What does current research indicate about the health effects of indoor toxic mold exposure and the recommended management?
In a 50-year-old man without cardiovascular disease, diabetes, or hypertension, who has normal LDL cholesterol, borderline low HDL cholesterol, and triglycerides of 300 mg/dL, what is the most appropriate next step in management?
What is the recommended treatment for carpal tunnel syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.